M.D.C. (NYSE:MDC) Now Covered by Analysts at StockNews.com

Equities researchers at StockNews.com initiated coverage on shares of M.D.C. (NYSE:MDCGet Free Report) in a research report issued to clients and investors on Wednesday. The firm set a “hold” rating on the construction company’s stock.

Several other research analysts have also issued reports on MDC. Evercore ISI lowered M.D.C. from an “outperform” rating to an “in-line” rating and raised their target price for the stock from $57.00 to $63.00 in a research report on Wednesday, January 31st. Raymond James reaffirmed a “market perform” rating on shares of M.D.C. in a research report on Wednesday, February 7th. One equities research analyst has rated the stock with a sell rating and five have assigned a hold rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $52.13.

Get Our Latest Stock Analysis on MDC

M.D.C. Stock Down 0.1 %

Shares of MDC opened at $62.91 on Wednesday. The stock has a market capitalization of $4.72 billion, a price-to-earnings ratio of 11.91 and a beta of 1.54. The company has a debt-to-equity ratio of 0.50, a quick ratio of 3.92 and a current ratio of 9.76. M.D.C. has a 52 week low of $36.47 and a 52 week high of $63.00. The stock has a fifty day moving average of $62.63 and a 200-day moving average of $52.05.

M.D.C. (NYSE:MDCGet Free Report) last announced its earnings results on Tuesday, January 30th. The construction company reported $1.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.50 by $0.06. The business had revenue of $1.31 billion during the quarter, compared to analyst estimates of $1.29 billion. M.D.C. had a return on equity of 12.32% and a net margin of 8.64%. M.D.C.’s revenue for the quarter was down 11.9% compared to the same quarter last year. During the same period last year, the company earned $1.08 EPS. As a group, sell-side analysts anticipate that M.D.C. will post 5.38 earnings per share for the current fiscal year.

Insider Transactions at M.D.C.

In other news, Director David E. Blackford sold 6,200 shares of M.D.C. stock in a transaction dated Monday, March 11th. The stock was sold at an average price of $62.69, for a total value of $388,678.00. Following the completion of the transaction, the director now directly owns 13,534 shares of the company’s stock, valued at approximately $848,446.46. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 23.30% of the company’s stock.

Institutional Trading of M.D.C.

Several large investors have recently made changes to their positions in MDC. Moneta Group Investment Advisors LLC acquired a new stake in shares of M.D.C. in the 4th quarter valued at about $263,371,000. Pacer Advisors Inc. grew its stake in shares of M.D.C. by 60.6% in the 4th quarter. Pacer Advisors Inc. now owns 2,492,733 shares of the construction company’s stock valued at $137,723,000 after buying an additional 940,810 shares during the period. Millennium Management LLC grew its stake in shares of M.D.C. by 259.7% in the 4th quarter. Millennium Management LLC now owns 593,177 shares of the construction company’s stock valued at $18,744,000 after buying an additional 428,286 shares during the period. Norges Bank acquired a new stake in shares of M.D.C. in the 4th quarter valued at about $13,291,000. Finally, Comerica Bank acquired a new stake in shares of M.D.C. in the 2nd quarter valued at about $167,930,000. 88.08% of the stock is currently owned by institutional investors and hedge funds.

About M.D.C.

(Get Free Report)

M.DC Holdings, Inc, through its subsidiaries, engages in the homebuilding and financial service businesses. Its homebuilding operations include purchasing finished lots or developing lots for the construction and sale primarily of single-family detached homes to first-time and first-time move-up homebuyers under the Richmond American Homes name.

Featured Articles

Analyst Recommendations for M.D.C. (NYSE:MDC)

Receive News & Ratings for M.D.C. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for M.D.C. and related companies with MarketBeat.com's FREE daily email newsletter.